Company / Book Value per Share
Arbutus Biopharma Corp Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$0.403
FY2025
5-year range
$0.403 / $1.889
FY2021-FY2025
Trend
-29.7%
vs FY2024
Sector context
#183 of 209
Health Care
What the data says
Arbutus Biopharma Corp's book value per share of $0.403 is lower than 88% of companies in the Health Care sector (FY2025). Book Value per Share has declined for 4 consecutive years, from $1.889 in FY2021 to $0.403 in FY2025.
Based on SEC 10-K filings.
$0.403 in FY2025 with a 5-year CAGR of -18.5%.
Declined from $0.673 to $0.403 over the past 2 years.
Health Care sector context is included.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -24.7%
- 5-Year CAGR
- -18.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 209This company $0.403 Sector average $189.406
▼
-99.8% below sector average
Key checks
Key Insights
- Arbutus Biopharma Corp's book value per share has declined for 4 consecutive years.
- 5-year CAGR of -18.5%, indicating a declining trend.
- In FY2025, book value per share decreased 29.7% year-over-year.
- Ranks #183 out of 209 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -11.01 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.403 | -29.7% |
| FY2024 | $0.573 | -14.9% |
| FY2023 | $0.673 | -28.7% |
| FY2022 | $0.944 | -50.0% |
| FY2021 | $1.889 | +68.3% |
| FY2020 | $1.123 | -68.9% |
| FY2019 | $3.607 | +8.8% |
| FY2018 | $3.314 | +0.0% |
| FY2017 | $3.314 | -10.5% |
| FY2016 | $3.702 | -63.1% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026